{
  "_originalData": {
    "identity": {
      "bacteriumName": "Corynebacterium urealyticum",
      "aliases": [],
      "lastUpdated": "2025-01-23",
      "clsiCategory": "Not classified by CLSI",
      "classification": {
        "gramStain": "Gram-positive",
        "morphology": "Rod (coryneform)",
        "respiration": "Aerobic",
        "notes": [
          "Strongly and rapidly urease-positive",
          "Lipophilic"
        ]
      },
      "strainDetails": [],
      "biochemicalTests": "Gram-positive rod (coryneform), non-motile, catalase +, oxidase –, strongly and rapidly urease +, lipophilic."
    },
    "clinicalProfile": {
      "summary": "Corynebacterium urealyticum is a multi-drug resistant uropathogen known for causing alkaline-encrusted cystitis and pyelitis. Its potent urease activity leads to the formation of struvite stones, which can cause obstruction and significant morbidity, particularly in renal transplant recipients.",
      "pathophysiologyPearls": [
        "The enzyme urease hydrolyzes urea into ammonia and carbon dioxide, raising urine pH.",
        "The alkaline urine promotes the precipitation of magnesium ammonium phosphate (struvite) and calcium phosphate, leading to the formation of stones and encrustations on uroepithelial surfaces."
      ],
      "keySignsAndSymptoms": [
        "Dysuria, frequency, urgency",
        "Hematuria",
        "Flank pain",
        "Fever",
        "Urinary obstruction"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Alkaline-Encrusted Cystitis/Pyelitis",
          "description": "Inflammation of the bladder and/or renal pelvis with the deposition of struvite crystals on the mucosal surfaces."
        },
        {
          "syndromeName": "Urinary Tract Infection (UTI)",
          "description": "Can present as a complicated UTI, often with underlying urological abnormalities."
        },
        {
          "syndromeName": "Struvite Stone Formation",
          "description": "Formation of infection-induced kidney stones that can lead to obstruction and renal damage."
        }
      ],
      "highRiskPopulations": [
        "Renal transplant recipients",
        "Patients with long-term urinary catheters",
        "Individuals with underlying urologic abnormalities",
        "Elderly and debilitated patients"
      ],
      "transmissionVectors": [],
      "prognosisNotes": [
        "In renal transplant patients, it can be associated with obstruction and graft loss."
      ]
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Beta-lactams",
          "notes": "Often resistant to most beta-lactams."
        },
        {
          "drugOrClass": "Aminoglycosides",
          "notes": "Often resistant."
        },
        {
          "drugOrClass": "Fluoroquinolones",
          "notes": "Often resistant."
        }
      ],
      "majorMechanisms": [],
      "clinicalAlerts": []
    },
    "treatment": {
      "generalNotes": [
        "Treatment requires both appropriate antimicrobial therapy and surgical intervention to remove stones and relieve obstruction."
      ],
      "drugsToAvoid": [],
      "adjunctiveTherapies": [
        {
          "therapy": "Surgical Intervention",
          "condition": "Encrusted pyelitis/cystitis, Struvite stones",
          "details": "Surgical removal of stones and encrustations is crucial for cure and to prevent recurrence."
        }
      ],
      "regimens": [
        {
          "context": {
            "type": "Directed",
            "condition": "Urinary Tract Infection",
            "patientPopulation": [
              "General"
            ],
            "isolateSource": "Urine"
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "14 days",
                  "drugs": [
                    {
                      "drugName": "Vancomycin",
                      "dose": "15-20 mg/kg",
                      "route": "IV",
                      "frequency": "q8-12h",
                      "comments": "Target AUC 400-600 µg/mL*hr or trough 15-20 µg/mL."
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "14 days",
                  "drugs": [
                    {
                      "drugName": "Teicoplanin",
                      "dose": "100-400 mg",
                      "route": "IM",
                      "frequency": "once daily",
                      "comments": "Where available."
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [
        "Persistent alkaline urine pH (>8.0) in a patient with UTI symptoms.",
        "Recurrent UTIs, especially with stone formation.",
        "UTI in a renal transplant recipient."
      ],
      "methodologyNotes": [
        "The organism may be slow-growing and require prolonged incubation."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "Diagnosis is made by urine culture. A persistently high urine pH is a key clue. Imaging is important to detect stones and encrustations.",
        "biosafetyWarning": "Standard BSL-2 practices are adequate.",
        "methods": []
      },
      "preventionAndScreening": [],
      "treatmentLifecycle": [],
      "antimicrobialStewardship": [],
      "drugSpecificPearls": [
        {
          "drugName": "Vancomycin",
          "pearl": "The drug of choice due to widespread resistance to other antibiotic classes."
        }
      ],
      "guidelineReferences": [
        {
          "source": "Clin Infect Dis",
          "citation": "46:825, 2008",
          "summaryOrNote": "Review of Corynebacterium urealyticum infections."
        },
        {
          "source": "Infect Drug Res",
          "citation": "8: 129, 2015",
          "summaryOrNote": "Review of Corynebacterium urealyticum infections."
        }
      ]
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.372Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Corynebacterium urealyticum"
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": []
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2025-01-23"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Gram-positive",
        "morphology": "Rod (coryneform)",
        "respiration": "Aerobic",
        "notes": [
          "Strongly and rapidly urease-positive",
          "Lipophilic"
        ]
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Corynebacterium urealyticum is a multi-drug resistant uropathogen known for causing alkaline-encrusted cystitis and pyelitis. Its potent urease activity leads to the formation of struvite stones, which can cause obstruction and significant morbidity, particularly in renal transplant recipients.",
      "pathophysiologyPearls": [
        "The enzyme urease hydrolyzes urea into ammonia and carbon dioxide, raising urine pH.",
        "The alkaline urine promotes the precipitation of magnesium ammonium phosphate (struvite) and calcium phosphate, leading to the formation of stones and encrustations on uroepithelial surfaces."
      ],
      "keySignsAndSymptoms": [
        "Dysuria, frequency, urgency",
        "Hematuria",
        "Flank pain",
        "Fever",
        "Urinary obstruction"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Alkaline-Encrusted Cystitis/Pyelitis",
          "description": "Inflammation of the bladder and/or renal pelvis with the deposition of struvite crystals on the mucosal surfaces."
        },
        {
          "syndromeName": "Urinary Tract Infection (UTI)",
          "description": "Can present as a complicated UTI, often with underlying urological abnormalities."
        },
        {
          "syndromeName": "Struvite Stone Formation",
          "description": "Formation of infection-induced kidney stones that can lead to obstruction and renal damage."
        }
      ],
      "highRiskPopulations": [
        "Renal transplant recipients",
        "Patients with long-term urinary catheters",
        "Individuals with underlying urologic abnormalities",
        "Elderly and debilitated patients"
      ],
      "transmissionVectors": [],
      "prognosisNotes": [
        "In renal transplant patients, it can be associated with obstruction and graft loss."
      ]
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Beta-lactams",
          "notes": "Often resistant to most beta-lactams."
        },
        {
          "drugOrClass": "Aminoglycosides",
          "notes": "Often resistant."
        },
        {
          "drugOrClass": "Fluoroquinolones",
          "notes": "Often resistant."
        }
      ],
      "majorMechanisms": [],
      "clinicalAlerts": []
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Urinary Tract Infection",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": "Urine"
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Vancomycin",
              "dose": "15-20 mg/kg",
              "route": "IV",
              "frequency": "q8-12h",
              "duration": "14 days",
              "comments": "Target AUC 400-600 µg/mL*hr or trough 15-20 µg/mL.",
              "originalText": "Vancomycin 15-20 mg/kg IV q8-12h"
            }
          ]
        },
        {
          "regimenId": "modern-0-1-0",
          "extractedFrom": "treatment.regimens[0].recommendations[1].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Urinary Tract Infection",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": "Urine"
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Teicoplanin",
              "dose": "100-400 mg",
              "route": "IM",
              "frequency": "once daily",
              "duration": "14 days",
              "comments": "Where available.",
              "originalText": "Teicoplanin 100-400 mg IM once daily"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [
        "Persistent alkaline urine pH (>8.0) in a patient with UTI symptoms.",
        "Recurrent UTIs, especially with stone formation.",
        "UTI in a renal transplant recipient."
      ],
      "methodologyNotes": [
        "The organism may be slow-growing and require prolonged incubation."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}